Exact Sciences (EXAS) Misses Q1 EPS by 21c, Updates Guidance

Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.54), $0.21 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $707 million versus the consensus estimate of $688.78 million.

GUIDANCE:

Exact Sciences sees FY2025 revenue of $3.07-3.12 billion, versus the consensus of $3.9 billion.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.

You May Also Be Interested In

• List of suppliers, parts, photos of iPhone 18 Pro are part of Tata Electronics data breach - Reuters
• JetBlue pilot says plane hit drone on landing at JFK
• Popular stocks with increasing option volume: MU INTC MSTR SPCX PLTR NFLX AVGO SOFI NOK